Patents by Inventor Massimo Costa

Massimo Costa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CELLULAR CULTURE MEDIUM FREE FROM SERUM
    Publication number: 20220041989
    Abstract: The present invention relates to a cell culture medium, in particular for culturing autologous fibroblasts, for use in aesthetic medicine for skin transplantation, said culture medium being serum-free and being characterized in that it contains glucose in a much lower quantity than conventional culture media.
    Type: Application
    Filed: October 20, 2021
    Publication date: February 10, 2022
    Applicant: Blast Research S.r.l.
    Inventors: Massimo Costa, Alberto Giuseppe Passi
  • CELLULAR CULTURE MEDIUM FREE FROM SERUM
    Publication number: 20180216071
    Abstract: The present invention relates to a cell culture medium, in particular for culturing autologous fibroblasts, for use in aesthetic medicine for skin transplantation, said culture medium being serum-free and being characterized in that it contains glucose in a much lower quantity than conventional culture media.
    Type: Application
    Filed: July 28, 2016
    Publication date: August 2, 2018
    Applicant: BLAST RESEARCH S.R.L.
    Inventors: Massimo Costa, Alberto Giuseppe Passi
  • Process for the preparation of anti-inflammatory pharmaceutical agents with an ibuprofen base, with elimination, in solution, of the bitter taste, burning of the throat and intestinal toxicity
    Patent number: 5180590
    Abstract: Anti-inflammatory pharmaceutical compositions with an ibuprofen base which eliminate the bitter taste, the burning in the throat and the topical toxicity at the level of the intestinal wall when their effervescent aqueous solutions are taken. The proportions among the main ingredients of each dose are the following: ibuprofen, 200 to 800 mg or ibuprofen sodium salt, 221.3 to 885.2 mg; sodium bicarbonate, 2.100 to 8.402 g; and citric acid, 0.450 to 1.800 g.
    Type: Grant
    Filed: June 13, 1989
    Date of Patent: January 19, 1993
    Assignee: Aesculapius-Pharma S.A.
    Inventors: Mario Carcano, Massimo Costa